Vodafone Idea: A funding boost
The stock price of Vodafone Idea shot up by more than 4% after media reports stated that the telecom service provider is in talks with several groups for fundraising.
According to a Bloomberg report, Oaktree Capital and Varde Partners are said to have offered Vodafone Idea at least $2 billion in funding.
Reacting to the news report, the shares of Vodafone Idea jumped as much as 4.23% to an intraday high of Rs 9.59 apiece on the BSE.
Vodafone Idea’s net debt stands at Rs 1,14510 crore.
The Board of Directors of the debt-laden telecom operator, at its meeting held on September 04, 2020, had approved the fund-raising plan of up to $ 2 billion or approximately Rs 25,000 crore.
In its post-earnings call with analysts, the company’s management had said that they were in discussions with several interested parties to raise funds through the debt and equity routes.
The interest was good and the ongoing discussions were progressing well, the company had said while being optimistic to conclude the fund-raise in two to three months.
Vodafone Idea is also set to receive Rs 3,760 crore cash for its 11.15% holding in Indus Towers following its merger with Bharti Infratel.
In the quarter ended September 2020, Vodafone Idea’s net loss narrowed to Rs 7,218.2 crore from Rs 50,897.9 crore in the same quarter of the previous fiscal. The average revenue per user (ARPU) increased to Rs 119 from Rs 107 in Q2FY20 and Rs 114 in Q1FY21.
Analysts believe Vodafone Idea needs Average Revenue Per User (ARPU) hike of more than 50% at the current EBITDA run rate in FY23E to meet the sharp jump in funding requirements.
This document is meant for the recipient only for use as intended and not for circulation. This document should not be reproduced or copied or made available to others. The information contained herein is from the public domain or sources believed to be reliable. While reasonable care has been taken to ensure that information given is at the time believed to be fair and correct and opinions based thereupon are reasonable, due to the very nature of research it cannot be warranted or represented that it is accurate or complete and it should not be relied upon as such. Also above note is not a recommendation to Buy or SELL and is only a view based on facts and figures and we will be in no way responsible for any losses incurred by anyone who uses this information to either trade or invests securities mentioned herein.